AU2001264872A1 - Method for synthesis of substituted azole libraries - Google Patents

Method for synthesis of substituted azole libraries

Info

Publication number
AU2001264872A1
AU2001264872A1 AU2001264872A AU6487201A AU2001264872A1 AU 2001264872 A1 AU2001264872 A1 AU 2001264872A1 AU 2001264872 A AU2001264872 A AU 2001264872A AU 6487201 A AU6487201 A AU 6487201A AU 2001264872 A1 AU2001264872 A1 AU 2001264872A1
Authority
AU
Australia
Prior art keywords
libraries
synthesis
substituted azole
azole
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264872A
Inventor
Dennis Hlasta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2001264872A1 publication Critical patent/AU2001264872A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
AU2001264872A 2000-06-05 2001-05-22 Method for synthesis of substituted azole libraries Abandoned AU2001264872A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20925200P 2000-06-05 2000-06-05
US60209252 2000-06-05
US60/209,252 2000-06-05
PCT/US2001/016727 WO2001094318A2 (en) 2000-06-05 2001-05-22 Method for synthesis of substituted azole libraries

Publications (1)

Publication Number Publication Date
AU2001264872A1 true AU2001264872A1 (en) 2001-12-17

Family

ID=22778010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264872A Abandoned AU2001264872A1 (en) 2000-06-05 2001-05-22 Method for synthesis of substituted azole libraries

Country Status (3)

Country Link
US (1) US6951948B2 (en)
AU (1) AU2001264872A1 (en)
WO (1) WO2001094318A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099760A1 (en) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc. Histone deacetylase inhibitors based on trihalomethylcarbonyl compounds
AU2004251987C1 (en) * 2003-06-30 2010-11-18 Daiichi Sankyo Company, Limited Heterocyclic methyl sulfone derivative
ATE443701T1 (en) * 2004-01-16 2009-10-15 Wyeth Corp HETEROCYCLIC AZOLE-CONTAINING SULFONAMIDINE INHIBITORS OF BETA-AMYLOID PRODUCTION
US7541472B2 (en) 2004-05-24 2009-06-02 Cropsolution, Inc. 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
NZ552510A (en) 2004-06-18 2010-12-24 Novartis Vaccines & Diagnostic N-(1-(1-benzyl-4-phenyl-1H-imidazol-2-yl)-2,2-dimethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (KSP) inhibitors for the treatment of cancer
EP1757290A1 (en) 2005-08-16 2007-02-28 Zentaris GmbH Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
AU2007215247B2 (en) * 2006-02-10 2012-12-13 Transtech Pharma, Llc Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
US7448642B2 (en) * 2006-04-11 2008-11-11 Honda Motor Co., Ltd. Impact absorbing airbag inflator
MX2009007260A (en) 2007-01-05 2009-07-10 Novartis Ag Cyclized derivatives as eg-5 inhibitors.
EP2431035A1 (en) 2010-09-16 2012-03-21 Æterna Zentaris GmbH Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
WO2020059841A1 (en) * 2018-09-21 2020-03-26 国立大学法人 長崎大学 Therapeutic agent for prion diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2207088A1 (en) 1996-06-14 1997-12-14 Eli Lilly And Company Scavenger assisted combinatorial process for preparing libraries of tertiary amine compounds
AU1455500A (en) * 1998-10-29 2000-05-22 Trega Biosciences, Inc. Oxadiazole, thiadiazole and triazole derivatives and combinatorial libraries thereof

Also Published As

Publication number Publication date
US20020042520A1 (en) 2002-04-11
WO2001094318A2 (en) 2001-12-13
US6951948B2 (en) 2005-10-04
WO2001094318A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2002237527A1 (en) Method of synthesizing camptothecin-relating compounds
AU2001284697A1 (en) Method of synthesizing diketopiperazines
PL344108A1 (en) Process for synthesizing cox-2 inhibitors
HUP0302755A3 (en) Method of synthesizing camptothecin-relating compounds
AU2792499A (en) Improved methods for synthesis of oligonucleotides
AU2002234047A1 (en) Pyrazole compounds useful as protein kinase inhibitors
AU2002231166A1 (en) Pyrazole compounds useful as protein kinase inhibitors
AU2001242673A1 (en) Method for the recording of an object space
AU2001264872A1 (en) Method for synthesis of substituted azole libraries
AU5860200A (en) Method for dp-conversion of an existing semi-submersible rig
AU2001291741A1 (en) Process for the synthesis of fluoroorganic compounds
AU2001266596A1 (en) Method for synthesis of substituted azole libraries
AU2002361357A1 (en) Method for monosulphonylation of an aminobenzofuran compound
AU2001252884A1 (en) Method of dopamine inhibition using l-threo-methylphenidate
AU2001268589A1 (en) Cross linked solid supports for solid phase synthesis
AU2002316593A1 (en) Solid phase synthesis of arylretinamides
AU2222499A (en) Method of synthesis of derivatives of aloesin
EP1250310A4 (en) Method for synthesizing hydrazodicarbonamide
AU2002237704A1 (en) Methods for the stereoselective synthesis of substituted piperidines
EP1243564A3 (en) Process for preventing formation of scale
AU2002231187A1 (en) Method for synthesizing diamond
AU2002222087A1 (en) Cyclizing method for synthesis of compounds derived from pyrrolidine
AU2002236882A1 (en) Improved methods for synthesis of oligonucleotides
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
AU2001249683A1 (en) Synthesis of thiazolium compounds